Neoplasia (New York, N.Y.) - JoVE Visualize

Showing results (491-500 of 2,753) with videos related to

Pageof 276

Sort By:

Neoplasia (New York, N.Y.)|March 31, 2026

AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanomaRupesh Paudel, Simon Goller, Stefanie Schwarz, et al.

Neoplasia (New York, N.Y.)|April 19, 2026

A MYC family switch: L-MYC drives and maintains neuroendocrine lineage programs in prostate cancerJeyaluxmy Sivalingam, Kaleigh Ballagh, Kyung Hyun Cho, et al.

Neoplasia (New York, N.Y.)|May 15, 2026

Quantitative dissection of radioresistance in cancer cells: Oxygen depletion-induced biological versus chemical mechanisms and baseline mechanisms governed by HIF-1β-NRF2/TXNRD1Satoshi Takeuchi, Minoru Kobayashi, Peter Wai Tik Lee, et al.

Neoplasia (New York, N.Y.)|March 13, 2026

Rational payload selection enables high antitumoral efficacy of an anti-EGFR antibody-drug conjugate against ovarian tumorsSheila Almaraz-Postigo, Mónica Redondo-Puente, Atanasio Pandiella

Neoplasia (New York, N.Y.)|February 18, 2026

Microbe-associated molecular patterns differentially mediate carcinogenic alterations of the breast tissue in the context of obesityMohamed Gaber, Lauren M Moulden, Adam S Wilson, et al.

Neoplasia (New York, N.Y.)|February 22, 2026

Mechanistic insights and therapeutic interventions of mitochondrial quality control in chemotherapy-related cognitive impairmentJie Chen, Xinyu Chu, Yue Wu, et al.

Neoplasia (New York, N.Y.)|February 12, 2026

Targeting the ANXA2-CD63-exosomal PD-L1 axis in hepatocellular carcinoma: A novel mechanism of immune evasion and its implications for precision immunotherapyJian Zhang, Ying Gu, Fangchao Zhao, et al.

Neoplasia (New York, N.Y.)|April 14, 2006

Nanoparticle imaging of integrins on tumor cellsXavier Montet, Karin Montet-Abou, Fred Reynolds, et al.

Neoplasia (New York, N.Y.)|December 18, 2007

Utility of a new bolus-injectable nanoparticle for clinical cancer stagingMukesh Harisinghani, Robert W Ross, Alexander R Guimaraes, et al.

Neoplasia (New York, N.Y.)|December 17, 2016

Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule InhibitorN Sumru Bayin, Lin Ma, Cheddhi Thomas, et al.

Pageof 276

Showing results (491-500 of 2,753) with videos related to

Sort By:

Pageof 276

Neoplasia (New York, N.Y.)|March 31, 2026

AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanomaRupesh Paudel, Simon Goller, Stefanie Schwarz, et al.

Neoplasia (New York, N.Y.)|April 19, 2026

A MYC family switch: L-MYC drives and maintains neuroendocrine lineage programs in prostate cancerJeyaluxmy Sivalingam, Kaleigh Ballagh, Kyung Hyun Cho, et al.

Neoplasia (New York, N.Y.)|May 15, 2026

Quantitative dissection of radioresistance in cancer cells: Oxygen depletion-induced biological versus chemical mechanisms and baseline mechanisms governed by HIF-1β-NRF2/TXNRD1Satoshi Takeuchi, Minoru Kobayashi, Peter Wai Tik Lee, et al.

Neoplasia (New York, N.Y.)|March 13, 2026

Rational payload selection enables high antitumoral efficacy of an anti-EGFR antibody-drug conjugate against ovarian tumorsSheila Almaraz-Postigo, Mónica Redondo-Puente, Atanasio Pandiella

Neoplasia (New York, N.Y.)|February 18, 2026

Microbe-associated molecular patterns differentially mediate carcinogenic alterations of the breast tissue in the context of obesityMohamed Gaber, Lauren M Moulden, Adam S Wilson, et al.

Neoplasia (New York, N.Y.)|February 22, 2026

Mechanistic insights and therapeutic interventions of mitochondrial quality control in chemotherapy-related cognitive impairmentJie Chen, Xinyu Chu, Yue Wu, et al.

Neoplasia (New York, N.Y.)|February 12, 2026

Targeting the ANXA2-CD63-exosomal PD-L1 axis in hepatocellular carcinoma: A novel mechanism of immune evasion and its implications for precision immunotherapyJian Zhang, Ying Gu, Fangchao Zhao, et al.

Neoplasia (New York, N.Y.)|April 14, 2006

Nanoparticle imaging of integrins on tumor cellsXavier Montet, Karin Montet-Abou, Fred Reynolds, et al.

Neoplasia (New York, N.Y.)|December 18, 2007

Utility of a new bolus-injectable nanoparticle for clinical cancer stagingMukesh Harisinghani, Robert W Ross, Alexander R Guimaraes, et al.

Neoplasia (New York, N.Y.)|December 17, 2016

Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule InhibitorN Sumru Bayin, Lin Ma, Cheddhi Thomas, et al.

Pageof 276